Delguercio Day Proceedings 2018
Fifteenth Annual Louis R.M. Del Guercio Distinguished Visiting Professorship and Research Day Presented at New York Medical College 7 Dana Road Facility Valhalla, New York December 19, 2018 PROCEEDINGS Program Committee: JORGE CON, MD THOMAS DIFLO, MD RIFAT LATIFI, MD KRIST NIKOLLA, MPH JOHN A. SAVINO, MD KATHRYN SPANKNEBEL, MD THOMAS SULLIVAN KEVIN WOLFE, PHD 1 Table of Contents: Podium Presentations…...............................p.03 Moderated Oral Poster Presentations…......p.29 Poster Exhibits…….…................................p.59 2 Podium Presentations (In alphabetical order) 3 TITLE: PREOPERATIVE MENINGIOMA EMBOLIZATION IS SAFE BUT COSTS MORE THAN NON- EMBOLIZATION RESECTIONS: A MULTI-CENTER RETROSPECTIVE MATCHED CASE-CONTROL STUDY Authors: ANUBHAV G. AMIN MD1(PGY6), John V. Wainwright MD1 , Ilya Rybkin MS2, Hussam Abou Al- Shaar MD3, William T. Couldwell MD/PhD4, Fawaz Al-Mulfti MD1, Justin Santarelli MD1, Chirag D. Gandhi MD1, Meic H. Schmidt MD1, Christian Bowers MD1 1 Department of Neurosurgery, Westchester Medical Center, New York Medical College, Valhalla, NY 2 New York Medical College, Valhalla, NY 3 Department of Neurosurgery, Hofstra/Northwell, Manhasset, NY 4 Department of Neurosurgery, University of Utah, Salt Lake City, UT Background: The literature has been mixed regarding the potential benefit of reduced blood loss with preoperative meningioma embolization (ME). However, a comparison of embolization-associated costs with non-embolization meningioma (NE) patients has not been completed. Objective: To determine the potential benefits of ME in blood loss and its associated costs. Design/Methods: This is a retrospective case control study matched for tumor location, size, and radiographic appearance between two centers. We reviewed demographic and clinical data for 29 matched meningioma patients from each center.
[Show full text]